AI Analysis AI Analysis of GERN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GERN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Geron Corporation
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 06, 2026 Loss -25.95%

The Geron Corporation stock price fell by -3.31% on the last day (Friday, 5th Jun 2026) from $1.21 to $1.17. During the last trading day the stock fluctuated 3.86% from a day low at $1.17 to a day high of $1.21. The price has fallen in 6 of the last 10 days and is down by -7.14% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -327 thousand shares and in total, 10 million shares were bought and sold for approximately $11.12 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.15 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -22.16% during the next 3 months and, with a 90% probability hold a price between $0.89 and $1.18 at the end of this 3-month period.

GERN Signals & Forecast

There are mixed signals in the stock today. The Geron Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.20 and $1.39. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 0.86%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Geron Corporation stock

Geron Corporation finds support from accumulated volume at $1.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0450 between high and low, or 3.86%. For the last week, the stock has had daily average volatility of 4.72%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GERN) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Geron Corporation to open at $1.18, and during the day (based on 14 day Average True Range), to move between $1.14 and $1.20, which gives a possible trading interval of +/-$0.0661 (+/-5.82%) up or down from last closing price. If Geron Corporation takes out the full calculated possible swing range there will be an estimated 5.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.16 (0.85%) than the resistance at $1.39 (18.80%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Geron Corporation stock A Buy?

Geron Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.726 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.18 ( 1.00%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GERN Performance

Trading levels for GERN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.23 4.84%
R2 1.21 3.37%
R1 1.20 2.47%
Price 1.17
S1 1.16 -0.472%
S2 1.15 -1.38%
S3 1.14 -2.85%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.46 24.79%
R2 1.40 19.66%
R1 1.39 18.80%
Price 1.17
S1 1.16 -0.85%
S2 0 -
S3 0 -

FAQ

What is the symbol for Geron Corporation Stock and on which exchange is it traded?
The symbol for Geron Corporation is GERN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Geron Corporation Stock?
Geron Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Geron Corporation Stock?
Geron Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Geron Corporation Stock.

What's the current price of Geron Corporation Stock?
As of the end of day on the Jun 05, 2026, the price of an Geron Corporation (GERN) share was $1.17.

What is the 52-week high and low for Geron Corporation Stock?
The 52-week high for Geron Corporation Stock is $2.01 and the 52-week low is $1.04.

What is the market capitalization of Geron Corporation Stock?
As of the Jun 05, 2026, the market capitalization of Geron Corporation is 750.58M.

When is the next earnings date for Geron Corporation?
The upcoming earnings date for Geron Corporation is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT GERON CORPORATION
Geron
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE